BIVALIRUDIN for Pulmonary embolism: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where BIVALIRUDIN was used for Pulmonary embolism.
Most Reported Side Effects for BIVALIRUDIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 148 | 17.6% | 12 | 72 |
| Haemorrhage | 79 | 9.4% | 7 | 22 |
| Off label use | 73 | 8.7% | 9 | 35 |
| Thrombosis in device | 63 | 7.5% | 9 | 8 |
| Vascular stent thrombosis | 63 | 7.5% | 14 | 15 |
| Heparin-induced thrombocytopenia | 61 | 7.3% | 8 | 38 |
| Thrombosis | 61 | 7.3% | 9 | 13 |
| Coagulation time abnormal | 42 | 5.0% | 3 | 2 |
| Gastrointestinal haemorrhage | 40 | 4.8% | 6 | 11 |
| Coronary artery thrombosis | 33 | 3.9% | 7 | 4 |
| Cardiac arrest | 28 | 3.3% | 25 | 16 |
| Haemorrhage intracranial | 20 | 2.4% | 7 | 6 |
| Kounis syndrome | 20 | 2.4% | 15 | 11 |
| Acute myocardial infarction | 19 | 2.3% | 7 | 10 |
| Ventricular fibrillation | 19 | 2.3% | 13 | 12 |
Other Indications for BIVALIRUDIN
Anticoagulant therapy (262)
Percutaneous coronary intervention (159)
Product used for unknown indication (134)
Heparin-induced thrombocytopenia (39)
Thrombosis prophylaxis (33)
Thrombosis (15)
Catheterisation cardiac (14)
Acute coronary syndrome (13)
Prophylaxis (13)
Coronary angioplasty (11)
Other Drugs Used for Pulmonary embolism
RIVAROXABAN (11,707)
APIXABAN (5,234)
WARFARIN (1,552)
ENOXAPARIN (1,155)
HEPARIN (786)
ALTEPLASE (617)
DABIGATRAN ETEXILATE (527)
DALTEPARIN (431)
EDOXABAN (307)
XARELTO (284)